GlassScriptPhysician profile
Graham Bobo
NPI 1134707870
$2,534.94
in general payments reported to CMS, 2019-2025
14 companies · $900 in 2025
The $900 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $474 · 2024: $1,160 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.95 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,088.49 | 2023-2025 | Titan, Saffron, Altis |
| Boston Scientific Corporation | $379.59 | 2024-2025 | Naviguide, Solyx Sis System, Ams 700 |
| Urogen Pharma, INC. | $274.00 | 2023-2025 | Jelmyto |
| Teleflex LLC | $251.17 | 2025 | Barrigel, Urolift |
| Astellas Pharma US INC | $127.74 | 2023-2024 | Xtandi |
| Karl Storz Endoscopy-America | $64.56 | 2023 | Flex-X |
| Ferring Pharmaceuticals INC. | $57.40 | 2024-2025 | Adstiladrin |
| Innovation Technologies INC | $56.01 | 2025 | Irrisept |
| Olympus America INC. | $52.49 | 2024 | Itind System |
| Janssen Biotech, INC. | $48.50 | 2025 | Erleada |
| Endo Pharmaceuticals INC. | $40.55 | 2023 | Xiaflex, Aveed |
| Medtronic, INC. | $40.07 | 2024 | Interstim |
| Bluewind Medical | $28.33 | 2024 | Revi |
| 180 Medical, INC. | $26.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graham Bobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.